Price $75.78 |
Market Cap
5.52B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
45.3
|
P/B
1.1
|
P/S
1.77
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
12.6
|
Op. Cash Flow
573.2K
|
FCF
6.5
|
|
Op. Margin
9.60%
|
Net Margin
3.80%
|
ROE
2.40%
|
ROI
8.40%
|
|
ROA
1.30%
|
EPS Growth
-91.60%
|
Current Ratio
1.6
|
Debt/Equity
49.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chromadex Corp (CDXC) | $1.42 | - | - | 117.7M | Strong Buy |
| Bimi International Medical Inc (BIMI) | $1.57 | - | - | 6.1M | Strong Buy |
| Baxter International Inc (BAX) | $38.96 | - | 2.50% | 23.05B | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $131.85 | - | - | 7.93B | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $1.60 | - | - | 6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
